ADIM
AHCO icon

Alpha DNA Investment Management’s AdaptHealth AHCO Stock Holding History

Alpha DNA Investment Management’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-62
Closed -$2K – 118
2021
Q1 		$2K Sell
62
-43
-41% -$1.52K ﹤0.01% 543
2020
Q4 		$3K Buy
+105
New +$3.25K ﹤0.01% 410

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alpha DNA Investment Management's AHCO Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of AdaptHealth (AHCO) in Q2 2021, closing a stake of 62 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in AHCO in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q4 2020. 137 funds tracked by Wall St. Rank hold AHCO as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining AdaptHealth position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 62 AdaptHealth shares in Q2 2021, an estimated $2K.
  • Alpha DNA Investment Management first reported a position in AdaptHealth in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's AdaptHealth position peaked at $3K in Q4 2020.
  • 137 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.